News

EfTEN Real Estate Fund Sees Growth Amidst Declining Rates

EfTEN Real Estate Fund Sees Growth Amidst Declining Rates

EfTEN Real Estate Fund AS Reports Positive Growth in 2024

The declining euro interest rates are been a boon for the Baltic real estate market, driving increased transaction activity and resulting in improved financial outcomes for EfTEN Real Estate Fund AS. In the third quarter of the year, the fund achieved a significant decline in consolidated interest expenses by more than 60 thousand euros from the previous quarter. This quarter has marked the most robust transaction activity in years for the Fund. Notably, the subsidiary, EfTEN Tähesaju tee OÜ, successfully sold the Tähesaju Hortes property and created two new wholly-owned subsidiaries aimed at acquiring logistics centers in Paemurru and Härgmäe, situated in Tallinn and Harjumaa. The anticipated acquisition cost for these two properties is projected to be close to 15 million euros upon completion.

Market Insights and Future Expectations

The expectation of further falling interest rates continues to bolster investor confidence. This trend has already positively influenced the prices of shares and bonds within the real estate sector across the Scandinavian exchanges. As outlined by the fund manager, positive financing attitudes from Nordic banks operating in the Baltic region create a fertile environment for the recovery of the Baltic commercial real estate sector, which has faced declines in recent years. However, it is important to note that localized major real estate investors currently lack capital, and the anticipated entry of foreign investors into the market remains elusive. Consequently, the market persists in being a buyer's market, providing opportunities to acquire premium real estate at favorable prices.

New Share Issue Announcement

Given the current market conditions, the fund has announced plans to initiate a share issue in the fall of 2024, seeking to raise additional equity of up to 30 million euros. At an extraordinary general meeting, the shareholders bestowed the necessary authorizations to the supervisory board and management for the organization of this substantial share issue.

Financial Overview

For the third quarter of 2024, the consolidated sales revenue of EfTEN Real Estate Fund AS reached 8.006 million euros, reflecting a minor increase from 7.965 million euros reported in the same quarter of the previous year. Over the first nine months of 2024, sales revenue climbed to 23.924 million euros from 23.714 million euros year-on-year. The group’s net rental income remained stable at 22.203 million euros compared to 22.201 million euros in the previous year. Expressively, the group obtained a net profit of 10.104 million euros during this timeframe, representing a marked increase from last year’s figure of 6.880 million euros.

Consolidated Net Rental Income Margin

The consolidated net rental income margin recorded was 93% in the first nine months of 2024, slightly down from 94% in 2023. This indicates that 7% of sales revenue was consumed by expenses directly linked to property management, including land tax, insurance, and maintenance costs.

Asset Performance and Investment Portfolio

As of September 30, 2024, the total asset volume of the group was valued at 377.723 million euros, reflecting a mild decline from 380.944 million euros at the end of 2023. Notably, 96% of this is attributed to the fair value of investment properties. The group possesses 34 commercial investment properties, valued at 358.577 million euros, demonstrating a modest progression since the 357.916 million euros recorded at year-end 2023. Furthermore, the group forged purchase agreements for the Härgmäe and Paemurru logistics centers in September 2024, contributing an advanced payment amounting to 2.173 million euros.

Recent Transactions

In the same period, the Tähesaju Hortes property was sold for 4.675 million euros. Moreover, the group retains a 50% interest in a joint venture owning the Palace Hotel in Tallinn, with a fair value of 8.543 million euros as of September 30, 2024.

Financing Strategies

Datewise data illustrates that during the first nine months of 2024, EfTEN’s subsidiaries, EfTEN Autokeskus OÜ and EfTEN Jurkalne SIA, successfully extended their loan agreements. In the coming 12 months, the expiration of loan agreements is anticipated for two subsidiaries, which currently stand at a total balance of 8.025 million euros as of September 30, 2024. With stable rental cash flows from the investment properties, the management is optimistic about extending these loan agreements without constraint.

Loan Dynamics and Interes Rates

The average interest rate across the group’s loan agreements currently stands at 5.35% as of September 30, 2024, a notable reduction from 5.91% at the end of 2023. All of the fund’s loan agreements are tied to floating interest rates.

Shareholder Information

As of September 30, 2024, the net value of EfTEN Real Estate Fund AS shares was set at 20.15 euros, reflecting a slight decrease from 20.21 euros reported at the end of the previous year. Despite the minor drop, the fund distributed 10.82 million euros in dividends in April 2024. The absence of profit distribution could have resulted in a remarkable 4.6% increase in share value during the past nine months.

Contact Information

For any inquiries, please reach out to:
Marilin Hein
CFO
Phone: +372 6559 515
Email: marilin.hein@eften.ee

Frequently Asked Questions

What is the current state of EfTEN Real Estate Fund's finances?

EfTEN Real Estate Fund reported an increased net profit of 10.104 million euros for the first nine months of 2024, supported by enhanced sales revenue.

How is EfTEN responding to declining interest rates?

The fund is experiencing reduced interest expenses and is optimistic about future financing opportunities, which could foster growth in the commercial real estate sector.

What properties has EfTEN acquired recently?

EfTEN established two new subsidiaries to acquire logistics centers in Paemurru and Härgmäe, with an expected total investment of nearly 15 million euros.

What is the outlook for share value?

Despite a slight decrease in the net share value, EfTEN's dividend payments indicate strong shareholder returns. Further, a lack of profit distribution could boost share value stability.

How is EfTEN managing its loans?

EfTEN's subsidiaries have successfully extended loan agreements and maintain a healthy level of debt management, demonstrating the ability to refinance loans due without difficulty.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Vaccinex Unveils Efficacy Insights for Pepinemab in Alzheimer’s Study

Updated Category News Views 71

Vaccinex Provides Update on Pepinemab Study for Alzheimer’s Disease ROCHESTER, N.Y. — Vaccinex, Inc. (NASDAQ: VCNX), a forward-thinking biotechnology firm, is making significant strides in the treatment of Alzheimer's disease (AD) and cancer. The company is focused on a unique approach through the inhibition of Semaphorin 4D (SEMA4D). Recently, it was announced that...

Continue Reading
Legal Inquiry into Netflix, Inc. (NFLX) Attracts Investor Attention

Updated Category News Views 287

Understanding the Investigation into Netflix, Inc. Recently, the law firm Robbins Geller Rudman & Dowd LLP has initiated a formal investigation into Netflix, Inc. (NASDAQ: NFLX). This inquiry primarily focuses on potential violations of U.S. federal securities laws that may have occurred within the company. The Implications for Investors This investigation comes at a...

Continue Reading
Norway's Wealth Fund Expands Portfolio with London Investment

Updated Category News Views 221

Norway's Sovereign Wealth Fund Takes Bold Step in London Norway's sovereign wealth fund, expertly managed by Norges Bank Investment Management, has recently made headlines with its strategic acquisition of a 25% stake in a notable portfolio of office and retail properties located in London's prestigious Mayfair district. Significant Investment in a Prime Location This...

Continue Reading
Exagen Inc. Announces New Biomarkers and Financial Success

Updated Category News Views 291

Exagen Inc. Introduces Groundbreaking Biomarkers for Autoimmune Diseases Innovative testing aims to enhance patient diagnosis and care Exagen Inc. (Nasdaq: XGN), a pioneering company in autoimmune testing, has achieved a significant milestone by receiving conditional approval from the New York State Department of Health for its advanced assays to diagnose systemic lupus...

Continue Reading
Pacaso's Financial Growth in 2025: A Closer Look At Results

Updated Category News Views 1306

Pacaso Shows Promising First Half Financial Performance Pacaso, the innovative platform for co-owned luxury vacation homes, has recently shared its financial results for the first half of 2025, demonstrating strong stability and improved efficiency despite a challenging broader housing market. The company reported an impressive adjusted gross profit while managing to...

Continue Reading